S. Alalousi et al., THE PROGNOSTIC-SIGNIFICANCE OF BASIC FIBROBLAST GROWTH-FACTOR IN CUTANEOUS MALIGNANT-MELANOMA, Journal of cutaneous pathology, 23(6), 1996, pp. 506-510
Basic fibroblast growth factor (bFGF) is a growth factor and an angiog
enesis factor which may play a role in the evolution of cutaneous mali
gnant melanoma (CMM). In this study, we evaluated the distribution of
bFGF in CMM using immunochemical methods and correlated the pattern of
bFGF expression with the clinical course. Formalin-fixed, paraffin-em
bedded sections of 46 CMMs were immunostained with a high-affinity pur
ified antibody raised against human bFGF. CMM were categorized into le
sions that exhibited subsequent recurrence (local, regional and/or sys
temic) or recurrence-free lesions. The minimum follow-up time was 5 ye
ars. Expression of bFGF within the tumors and in peritumoral and intra
tumoral blood vessels was similar in the two groups. Comparable result
s were attained when 8 recurring vs 8 non-recurring CMM, selected from
the above tumors, were matched for age, gender, anatomic site and tum
or thickness. These results suggest that the biologic behavior of CMM
may not be predicted by immunoreactivity to bFGF in CMM cells or in th
e local tumor vasculature. (C) Munksgaard 1996.